Literature DB >> 18716411

Environmental epidemiology of essential tremor.

Elan D Louis1.   

Abstract

BACKGROUND: Essential tremor (ET) is one of the most common neurological disorders. Despite this, the disease mechanisms and etiology are not well understood. While susceptibility genotypes undoubtedly underlie many ET cases, no ET genes have been identified thus far. As with many other progressive, degenerative neurological disorders, it is likely that environmental factors contribute to the etiology of ET. Environmental epidemiology is the study in specific populations or communities of the effect on human health of physical, biologic and chemical factors in the external environment. The purpose of this article is to review current knowledge with regards to the environmental epidemiology of ET.
RESULTS: As will be discussed, a series of preliminary case-control studies in recent years has begun to explore several candidate toxins/exposures, including harmane (1-methyl-9H-pyrido[3,4-b]indole), lead and agricultural exposures/pesticides.
CONCLUSIONS: While several initial results are promising, as will be discussed, additional studies are needed to more definitively establish whether these exposures are associated with ET and if they are of etiological importance. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716411      PMCID: PMC2683985          DOI: 10.1159/000151523

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  191 in total

Review 1.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

2.  CYP2C19 polymorphism and risk for essential tremor.

Authors:  Hortensia Alonso-Navarro; Carmen Martínez; Elena García-Martín; Julián Benito-León; Isabel García-Ferrer; Pilar Vázquez-Torres; Inmaculada Puertas; Tomás López-Alburquerque; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Eur Neurol       Date:  2006-09-08       Impact factor: 1.710

Review 3.  Exploring the relationship between essential tremor and Parkinson's disease.

Authors:  Joohi Shahed; Joseph Jankovic
Journal:  Parkinsonism Relat Disord       Date:  2006-08-02       Impact factor: 4.891

4.  Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.

Authors:  D A Gearhart; M A Collins; J M Lee; E J Neafsey
Journal:  Neurobiol Dis       Date:  2000-06       Impact factor: 5.996

5.  Essential tremor in Papua, New Guinea.

Authors:  R W Hornabrook; J T Nagurney
Journal:  Brain       Date:  1976-12       Impact factor: 13.501

6.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

7.  Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD.

Authors:  E D Louis; G Levy; H Mejia-Santana; L Cote; H Andrews; J Harris; C Waters; B Ford; S Frucht; S Fahn; R Ottman; K Marder
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

8.  Glutathione-S-transferase P1 polymorphism and risk for essential tremor.

Authors:  C Martínez; E García-Martín; H Alonso-Navarro; J Benito-León; I Puertas; L Rubio; T López-Alburquerque; J A G Agúndez; F J Jiménez-Jiménez
Journal:  Eur J Neurol       Date:  2008-01-22       Impact factor: 6.089

9.  Ibogaine induces glial activation in parasagittal zones of the cerebellum.

Authors:  E O'Hearn; D B Long; M E Molliver
Journal:  Neuroreport       Date:  1993-03       Impact factor: 1.837

Review 10.  The role of metals in the etiology of Alzheimer's disease.

Authors:  Ivan Shcherbatykh; David O Carpenter
Journal:  J Alzheimers Dis       Date:  2007-05       Impact factor: 4.472

View more
  33 in total

Review 1.  Challenges in essential tremor genetics.

Authors:  L N Clark; E D Louis
Journal:  Rev Neurol (Paris)       Date:  2015-05-21       Impact factor: 2.607

Review 2.  Essential tremor then and now: How views of the most common tremor diathesis have changed over time.

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2017-07-13       Impact factor: 4.891

3.  Prevalence of Essential Tremor in the Faroe Islands: A Population-Based Study.

Authors:  Eina H Eliasen; Monica Ferrer; Shahin Gaini; Elan D Louis; Maria Skaalum Petersen
Journal:  Neuroepidemiology       Date:  2019-03-19       Impact factor: 3.282

4.  Autosomal dominant essential tremor: a novel family with anticipation.

Authors:  Elena Pasini; Giorgia Busolin; Carlo Nobile; Roberto Michelucci
Journal:  Neurol Sci       Date:  2012-10-13       Impact factor: 3.307

5.  Blood Harmane (1-Methyl-9H-Pyrido[3,4-b]indole) and Mercury in Essential Tremor: A Population-Based, Environmental Epidemiology Study in the Faroe Islands.

Authors:  Elan D Louis; Eina H Eliasen; Monica Ferrer; Daniella Iglesias Hernandez; Shahin Gaini; Wendy Jiang; Wei Zheng; Flemming Nielsen; Maria Skaalum Petersen
Journal:  Neuroepidemiology       Date:  2020-01-31       Impact factor: 3.282

Review 6.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

Review 7.  Essential tremor.

Authors:  Lorraine N Clark; Elan D Louis
Journal:  Handb Clin Neurol       Date:  2018

Review 8.  An update on essential tremor.

Authors:  Rodger J Elble; Günther Deuschl
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

9.  Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in dystonia cases vs. controls.

Authors:  Elan D Louis; Pam Factor-Litvak; Monika Michalec; Wendy Jiang; Wei Zheng
Journal:  Neurotoxicology       Date:  2014-06-23       Impact factor: 4.294

Review 10.  Understanding essential tremor: progress on the biological front.

Authors:  Elan D Louis
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.